Boston Scientific-jp-morgan-healthcare-conference-2025.pdf

1、JP Morgan Healthcare Conference 2025Mike Mahoney,Chairman and Chief Executive Officer2This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.Forward-looking statements may be identif

2、ied by words like anticipate,expect,project,believe,plan,estimate,may,intend and similar words.These forward-looking statements are based on our beliefs,assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.These

3、 forward-looking statements include,among other things,statements regarding our business plans,strategy,performance and goals,including environmental,social and governance(ESG)plans,financial performance and capital allocation priorities,expected net sales,reported,operational and organic revenue gr

4、owth rates,reported and adjusted earnings per share(EPS),operating margin,free cash flow(FCF),acquisitions and investments,litigation,clinical trials,new and anticipated product launches and approvals and product performance and impact.If our underlying assumptions turn out to be incorrect,or if cer

5、tain risks or uncertainties materialize,actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.These factors,in some cases,have affected and in the future(together with other factors)could affect our ability to implement our

6、business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this presentation.As a result,readers are cautioned not to place undue reliance on any of our forward-looking statements.Factors that may cause such differences can be found in